Free release
N-(2-Methyl-2-(2-phenyloxazol-4-yl)propyl)-3-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide

N-(2-Methyl-2-(2-phenyloxazol-4-yl)propyl)-3-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide

CAS No. :1314891-22-9MDL No. :MFCD26522024Formula :C23H19F3N4O3Boiling Point :-Linear Structure Formula :-InChI Key :QTC

Sales:Service@apichina.com
CAS No. :1314891-22-9 Brand :Qitai
Formula :C23H19F3N4O3 M.W :456.42

Introduction

CAS No. :1314891-22-9 MDL No. :MFCD26522024
Formula : C23H19F3N4O3 Boiling Point : -
Linear Structure Formula :- InChI Key :QTCSXAUJBQZZSN-UHFFFAOYSA-N
M.W : 456.42 Pubchem ID :67324851
Synonyms :
TFMO 2
Chemical Name :N-(2-Methyl-2-(2-phenyloxazol-4-yl)propyl)-3-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide

Physicochemical Properties

Num. heavy atoms : 33
Num. arom. heavy atoms : 22
Fraction Csp3 : 0.22
Num. rotatable bonds : 8
Num. H-bond acceptors : 9.0
Num. H-bond donors : 1.0
Molar Refractivity : 112.02
TPSA : 94.05 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.58 cm/s

Lipophilicity

Log Po/w (iLOGP) : 4.1
Log Po/w (XLOGP3) : 4.94
Log Po/w (WLOGP) : 6.27
Log Po/w (MLOGP) : 3.32
Log Po/w (SILICOS-IT) : 5.12
Consensus Log Po/w : 4.75

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 1.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.75
Solubility : 0.000817 mg/ml ; 0.00000179 mol/l
Class : Moderately soluble
Log S (Ali) : -6.65
Solubility : 0.000102 mg/ml ; 0.000000223 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -9.24
Solubility : 0.000000261 mg/ml ; 0.0000000006 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.57
Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram: